Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Antimicrobial Agents|July 3, 2014
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacinC Magis-Escurra, H M J Later-Nijland, J W C Alffenaar, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacyD M Burger, P W Hugen, R E Aarnoutse, et al.Antimicrobial Agents and Chemotherapy|August 23, 2017
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary TuberculosisR E Aarnoutse, G S Kibiki, K Reither, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 19, 2019
Management of patients with multidrug-resistant tuberculosisC Lange, R E Aarnoutse, J W C Alffenaar, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.Pageof 3